Teva sees obstacles to copying GSK's Advair drug before 2018

[riky]

Teva sees obstacles to copying GSK's Advair drug before 2018

LONDON (Reuters) - Teva Pharmaceuticals does not expect to see the launch of generic copies of GlaxoSmithKline's best-selling lung drug Advair that could be sold as a true substitute to U.S. patients before 2018. The cautious comments by the world's biggest maker of generic medicines during an investor presentation on Tuesday is good news for GSK shareholders, who had feared cheaper forms of the $8 billion-a-year seller might come around two years sooner. ...

Source: You are not allowed to view links. Register or Login